Clinical significance of tumor abnormal protein in patients with type 2 diabetes complicated with lung adenocarcinoma in situ

References

• Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes atlas: global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2022;183:1. doi:10.1016/j.diabres.2021.109118.
   Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–6. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Briana DD, Malamitsi-Puchner A. Galectin-3: an early marker of gestational diabetes, subclinical atherosclerosis, and tumor progression. Angiology. 2020;71(5):474–474. doi:10.1177/0003319719831870.
   PubMed Web of Science ®Google Scholar
• Nam H, Hong SS, Jung KH, et al. A serum marker for early pancreatic cancer with a possible link to diabetes. J Natl Cancer Inst. 2022;114(2):228–234. doi:10.1093/jnci/djab191.
   PubMedGoogle Scholar
• Hong T, Qin N, Zhao X, et al. Investigation of causal effect of type 2 diabetes mellitus on lung cancer: a mendelian randomization study. Front Genet. 2021;12:673687. doi:10.3389/fgene.2021.673687.
   PubMedGoogle Scholar
• Liu Z, Cai J, Yu Y, et al. Tumor abnormal protein as a novel biomarker in papillary thyroid carcinoma. Clin Lab. 2017;63(3):479–485. doi:10.7754/Clin.Lab.2016.160903.
   PubMed Web of Science ®Google Scholar
• Chen WX, Yang LG, Cheng L, et al. Tumor abnormal protein in the diagnosis of breast cancer in patients with a palpable mass. Ann Clin Lab Sci. 2019;49(3):297–301.
   PubMed Web of Science ®Google Scholar
• Chen R, Jiang C, Zhu Q, et al. Combining the tumor abnormal protein test with tests for carcinoembryonic antigens, cancer antigen 15-3, and/or cancer antigen 125 significantly increased their diagnostic sensitivity for breast cancer. Medicine (Baltimore). 2020;99(29):e21231. doi:10.1097/MD.0000000000021231.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang X, Wang Z. Early study of tumor abnormal protein in gastric adenocarcinoma. Onco Targets Ther. 2021;14:1719–1726. doi:10.2147/OTT.S297413.
   PubMed Web of Science ®Google Scholar
• Zhang L, Guo X, Min Y, et al. Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer. Int J Clin Exp Med. 2015;8(10):18528–18532.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Fang Q, Chen Y, et al. High expression of tumor abnormal protein preoperatively predicts poor prognosis of patients with esophageal squamous cell carcinoma. Front Surg. 2021;8:609719. doi:10.3389/fsurg.2021.609719.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Crowley J, Chansky K, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2(8):706–714. doi:10.1097/JTO.0b013e31812f3c1a.
   PubMed Web of Science ®Google Scholar
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183–1197. doi:10.2337/diacare.20.7.1183.
   PubMed Web of Science ®Google Scholar
• Navani N, Booth HL, Kocjan G, et al. Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. Respirology. 2011;16(3):467–472. doi:10.1111/j.1440-1843.2011.01933.x.
   PubMed Web of Science ®Google Scholar
• Fiala O, Pesek M, Finek J, et al. Prognostic significance of serum tumor markers in patients with advanced-stage NSCLC treated with pemetrexed-based chemotherapy. Anticancer Res. 2016;36(1):461–466.
   PubMed Web of Science ®Google Scholar
• Wu FT, Wu W, Li XT, et al. Tumor abnormal protein level predicts disease response and progression of diffuse large B-cell lymphoma in the rituximab era. Clin Lab. 2019. doi:10.7754/Clin.Lab.2019.190631.
   Web of Science ®Google Scholar
• Cheng Y, Chen Y, Zang G, et al. Increased expression of TAP is predictive of poor prognosis in patients with Non-Small cell lung cancer. Cancer Manag Res. 2020;12:1941–1946. doi:10.2147/CMAR.S239593.
   PubMed Web of Science ®Google Scholar
• Yi ZH, Luther Y, Xiong GH, et al. Association between diabetes mellitus and lung cancer: meta-analysis. Eur J Clin Invest. 2020;50(10):e13332.
   PubMed Web of Science ®Google Scholar
• Shlomai G, Neel B, LeRoith D, et al. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy. J Clin Oncol. 2016;34(35):4261–4269. doi:10.1200/JCO.2016.67.4044.
   PubMed Web of Science ®Google Scholar
• Zhu XW, Deng FY, Lei SF. Meta-analysis of atherogenic index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Prim Care Diabetes. 2015;9(1):60–67. doi:10.1016/j.pcd.2014.03.007.
   PubMed Web of Science ®Google Scholar
• Yang T, Liu Y, Li L, et al. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21(1):93. doi:10.1186/s12933-022-01531-7.
   PubMed Web of Science ®Google Scholar
• Naseri K, Saadati S, Yari Z, et al. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: a grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials. Pharmacol Res. 2022;182:106288. doi:10.1016/j.phrs.2022.106288.
   PubMed Web of Science ®Google Scholar
• Ma A, Fan D, Yan F. A study of the application of TAP combined with transvaginal ultrasound in the diagnosis of early-stage endometrial cancer. Oncol Lett. 2018;16(4):5186–5190. doi:10.3892/ol.2018.9250.
   PubMed Web of Science ®Google Scholar
• Wang HJ, Liu H, Lin YH, et al. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy. Hum Exp Toxicol. 2021;40(4):587–595. doi:10.1177/0960327120952157.
   PubMed Web of Science ®Google Scholar
• Li LX, Zhang B, Gong RZ. Insights into the role of tumor abnormal protein in early diagnosis of cancer: a prospective cohort study. Medicine (Baltimore). 2020;99(11):e19382. doi:10.1097/MD.0000000000019382.
   PubMed Web of Science ®Google Scholar
• Khateeb J, Fuchs E, Khamaisi M. Diabetes and lung disease: a neglected relationship. Rev Diabet Stud. 2019;15(1):1–15. doi:10.1900/RDS.2019.15.1.
   PubMedGoogle Scholar